Eisai: Gilead Sciences Submits New Drug Application in Japan for Filgotinib for the Treatment of Ulcerative Colitis with an Inadequate Response to Conventional Therapies
- Written by ACN Newswire - Press Releases
.
Deputy partners with SuperAPI to streamline employee onboarding and help get shift-based industries ready for PayDay Super
Deputy, the global people platform for shift-based work, has announced a new partnership with SuperAPI, marking a major enhancement to its HR pro...
KuCoin invests in Australian sponsorships of the ACC, plus a major campaign with golf icon Adam Scott
KuCoin, a leading global crypto platform built on trust, announced the appointment of James Pinch as the Australian Managing Director, the establish...
Australian companies pitching to the world’s wealthiest investors
#CapTech 2025 to bring world investors to Australia’s doorstep One of Australia’s leading business and capital events is bringing together inves...
Small business backlash builds as RBA’s surcharge ban risks fuelling inflation
Australia’s small business sector has launched a fierce campaign against the Reserve Bank of Australia’s (RBA) proposed ban on debit and credit card...
Australia’s Young Entrepreneurs Redefining Success Through Legacy and Community Impact
A new generation of young Australian small business owners is redefining success, driven by a desire to create a lasting legacy through the positi...
Lessons in AI: How LoanOptions.ai Shows What Smart Adoption Really Looks Like
In a world where many small businesses are still trying to work out how to actually use AI (not just talk about it), Australian fintech LoanOption...